תבנית:תרופה/קופגוס - Copegus: הבדלים בין גרסאות

Copegus in combination with peginterferon alfa 2a or interferon alfa - 2a is indicated in adult patients who are positive for serum HCV-RNA, including patients with compensated cirrhosis . The combination with peginterferon alfa-2a is also indicated in patients co-infected with clinically stable HIV , including patients with compensated cirrhosis . Copegus, in combination with peginterferon alfa-2a, is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated) alone or in combination therapy with ribavirin.